We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
3 hedge funds and large institutions have $58K invested in Interpace Biosciences, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% less funds holding
Funds holding: 12 → 3 (-9)
82% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 11
93% less capital invested
Capital invested by funds: $849K → $58K (-$791K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
3
Holders Change
-9
Holders Change %
-75%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$49.1K |
| 2 |
RG
Retirement Group
San Diego,
California
|
+$4.41K |
Top Sellers
| 1 |
BlackRock
New York
|
-$368K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$253K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$101K |
| 4 |
Squarepoint
New York
|
-$65K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$40K |